Welcome to our dedicated page for Celanese SEC filings (Ticker: CE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Celanese's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Celanese's regulatory disclosures and financial reporting.
Celanese Corporation (CE) director Timothy Go reported an acquisition of 0.86 phantom stock units on 11/12/2025 (Transaction Code: A). Each phantom stock unit represents the right to receive one share of common stock.
The units reflect dividend equivalents credited under the company’s 2008 Deferred Compensation Plan and become payable in common stock following the end of his service as a director. After this transaction, his directly held derivative securities balance is 1,115.57 units.
Celanese (CE) director Edward G. Galante reported an acquisition of 5.21 phantom stock units on 11/12/2025 under a Form 4 filing. Following this transaction, he beneficially owns 6,802.765 derivative securities.
The transaction was coded A (acquired). Each phantom stock unit represents the right to receive one share of common stock. The reported phantom stock reflects dividend equivalents on compensation deferred under the Company’s 2008 Deferred Compensation Plan and becomes payable in shares of common stock after his service as a director ends. The filing lists a Price of Derivative Security of $39.12.
Celanese Corporation (CE) reported a large GAAP loss driven by non‑cash impairments. For Q3 2025, net sales were $2,419 million and net loss was $1,353 million as Other (charges) gains, net totaled $1,491 million. Operating loss was $1,275 million. Year‑to‑date, net sales were $7,340 million with a net loss of $1,173 million.
The quarter included a goodwill impairment of about $1.0 billion in Engineered Materials, an additional $98 million linked to the Micromax® held‑for‑sale classification, and a $346 million impairment of certain trade names. Cash from operations rose to $894 million for the nine months, lifting cash to $1,440 million and shareholders’ equity to $3,954 million. The company signed an agreement on October 28, 2025 to divest its Micromax® portfolio to Element Solutions for approximately $500 million in cash, subject to adjustments and approvals. Celanese also announced plans to close its Lanaken, Belgium facility, expecting $70–$90 million of exit and shutdown costs during 2026–2028.
Debt stood at $11,655 million long‑term (net), with March 2025 note issuances of $700 million (2030, 6.500%), €750 million (2031, 5.000%) and $1,100 million (2033, 6.750%), alongside tender offers for €552 million (2026) and $500 million (2027) notes.
Celanese Corporation announced a Regulation FD webcast for investors and analysts on November 7, 2025 at 9:00 a.m. ET to discuss its third quarter 2025 results. CEO Scott A. Richardson will present, with materials available at investors.celanese.com under News & Events.
The company furnished exhibits including prepared remarks and a slide presentation (Exhibits 99.1(a) and 99.1(b)). Non‑US GAAP measures referenced in the remarks are defined and reconciled to the most comparable US GAAP metrics in Exhibit 99.2. These materials are furnished, not filed.
Celanese Corporation (CE) furnished an 8-K announcing it issued a press release reporting financial results for the third quarter of 2025. The press release is provided as Exhibit 99.1.
Non‑US GAAP measures referenced in the release are reconciled to the most comparable US GAAP measures in Exhibit 99.2. The information was furnished under Item 2.02 and is not deemed filed under the Exchange Act.
Celanese Corporation announced it signed a purchase and sale agreement with Element Solutions Inc to divest the Company’s Micromax® portfolio of products. The closing is described as being subject to regulatory approval and other closing conditions.
The Company furnished a press release as Exhibit 99.1 and included forward‑looking statements referencing expected timing, future performance, and deleveraging efforts. The disclosure was furnished under Regulation FD and is not deemed filed for liability purposes.
Celanese Corporation announced its intent to close its acetate tow facility in Lanaken, Belgium to streamline production costs across its global network. The company plans to permanently cease manufacturing operations in the second half of 2026, subject to a consultation process with the facility’s works council and union representatives.
Celanese expects total expenses of $70–90 million, including $55–65 million of non-cash accelerated depreciation of fixed assets and $15–25 million of other shutdown cash costs. The company expects cash outflows related to these actions during fiscal years 2026 through 2028. Employee termination costs will be determined following the consultation and disclosed afterward. Actual charges may vary depending on the consultation outcome.
Timothy Go, a director of Celanese Corporation (CE), reported two open-market purchases of Common Stock on 09/08/2025. The Form 4 shows 500 shares bought at $46.33 and 539 shares bought at $46.175, leaving him with 4,415 total shares beneficially owned after the transactions. The filing was signed by an attorney-in-fact on 09/09/2025.
Mark Christopher Murray, reported as an officer (SVP - Acetyls) of Celanese Corporation (CE), acquired 2,017 shares of Celanese common stock on 08/14/2025 at a reported price of $41.83 per share. Following the transaction the filing reports 17,000 shares beneficially owned in a direct ownership form. The Form 4 was signed by an attorney-in-fact on 08/18/2025. No derivative transactions are reported on this filing.
Celanese Corporation (CE) director Scott McDougald reported a non-derivative purchase of 2,000 shares on 08/14/2025 at a price of $40.8935 per share, increasing his direct beneficial ownership to 20,376 shares. The Form 4 was signed by an attorney-in-fact on 08/18/2025. No derivative transactions or additional remarks were reported.